IOVANCE BIOTHERAPEUTICS, INC. Uncategorized Contracts & Agreements

22 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Iovance Biotherapeutics, Inc. Amended and Restated 2021 Inducement Plan
IOVANCE BIOTHERAPEUTICS, INC.
2024
Open Market Sale Agreement dated June 16, 2023, by and between Iovance Biotherapeutics, Inc. and Jefferies LLC
IOVANCE BIOTHERAPEUTICS, INC.
2023
Open Market Sale Agreement dated November 18, 2022, by and between Iovance Biotherapeutics, Inc. and Jefferies LLC
IOVANCE BIOTHERAPEUTICS, INC.
Biotechnology
NY
2022
Iovance Biotherapeutics, Inc. Amended and Restated 2021 Inducement Plan
IOVANCE BIOTHERAPEUTICS, INC.
Biotechnology
DE
2022
Iovance Biotherapeutics, Inc. 2021 Inducement Plan
IOVANCE BIOTHERAPEUTICS, INC.
Biotechnology
DE
2021
Open Market Sale Agreement dated February 8, 2021, by and between Iovance Biotherapeutics, Inc. and Jefferies LLC
IOVANCE BIOTHERAPEUTICS, INC.
Biotechnology
NY
2021
First Amendment dated as of February 8, 2021, by and between Iovance Biotherapeutics, Inc. and Hudson Skyway Landing, LLC
IOVANCE BIOTHERAPEUTICS, INC.
Biotechnology
CA
2021
Second Amendment dated as of February 8, 2021, by and between Iovance Biotherapeutics, Inc. and Hudson Skyway Landing, LLC
IOVANCE BIOTHERAPEUTICS, INC.
Biotechnology
2021
Description of Securities
IOVANCE BIOTHERAPEUTICS, INC.
Biotechnology
2020
Second Amendment to the Strategic Alliance Agreement between Iovance Biotherapeutics, Inc., and The University of Texas M.D. Anderson Cancer Center, effective February 16, 2018
IOVANCE BIOTHERAPEUTICS, INC.
Biotechnology
2018
First Amendment to the Strategic Alliance Agreement between Lion Biotechnologies, Inc., and The University of Texas M.D. Anderson Cancer Center, effective August 2, 2017
IOVANCE BIOTHERAPEUTICS, INC.
Biotechnology
2018
PLANOF CONVERSION OF LION BIOTECHNOLOGIES, INC. A Nevada Corporation INTO LION BIOTECHNOLOGIES, INC. A Delaware Corporation
IOVANCE BIOTHERAPEUTICS, INC.
Biotechnology
NV
2017
AMENDMENT NO. 1 TO EXECUTIVE EMPLOYMENTAGREEMENT
IOVANCE BIOTHERAPEUTICS, INC.
Biotechnology
2016
BOARD ADVISER AGREEMENT
IOVANCE BIOTHERAPEUTICS, INC.
Biotechnology
NY
2016
NATIONAL INSTITUTES OF HEALTH FIRST AMENDMENT TO L-107-2015/0
IOVANCE BIOTHERAPEUTICS, INC.
Biotechnology
2015
AMENDMENT NO. 1 TO EXECUTIVE EMPLOYMENTAGREEMENT
IOVANCE BIOTHERAPEUTICS, INC.
Biotechnology
2015
Text MarkedBy [* * *] Has Been Omitted Pursuant To A Request For Confidential Treatment And Was Filed Separately With The Securities AndExchange Commission. THENational Institutes...
IOVANCE BIOTHERAPEUTICS, INC.
Biotechnology
2015
MATURITY DATE EXTENSION
IOVANCE BIOTHERAPEUTICS, INC.
Biotechnology
2012
MATURITY DATE EXTENSION
IOVANCE BIOTHERAPEUTICS, INC.
Biotechnology
2012
LETTER OF INTENT
IOVANCE BIOTHERAPEUTICS, INC.
Biotechnology
DE
2011
GENESIS BIOPHARMA, INC. OPTION CERTIFICATE
IOVANCE BIOTHERAPEUTICS, INC.
Biotechnology
NV
2011
DATED 15TH MARCH2010 (1)CANCER RESEARCH TECHNOLOGY LIMITED AND (2)GENESIS BIOPHARMA, INC.
IOVANCE BIOTHERAPEUTICS, INC.
Biotechnology
2010